| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accounting for Tumour Movement in the Upper Abdomen using Fiducial-free Stereotactic Radiotherapy in Expiration Breath Hold: a Case Report
|
Phillips, I.
|
|
2018
|
30 |
6 |
p. e56
|
artikel
|
| 2 |
A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain
|
Ranger, A.
|
|
2018
|
30 |
6 |
p. 346-353
|
artikel
|
| 3 |
Analysis of On-trial Quality Assurance for the SPARC Clinical Trial using Novel Peer-review Methodology
|
Holyoake, D.
|
|
2018
|
30 |
6 |
p. e60
|
artikel
|
| 4 |
An Audit of a New Frameless Immobilisation System for Patients Receiving Stereotactic Radiosurgery at One Institution
|
Clements, R.
|
|
2018
|
30 |
6 |
p. e57
|
artikel
|
| 5 |
An Evaluation of Marker-based Registration of CT and MR Examinations for Liver SABR Planning
|
Woolcot, T.
|
|
2018
|
30 |
6 |
p. e55
|
artikel
|
| 6 |
Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases
|
Agarwal, J.P.
|
|
2018
|
30 |
6 |
p. 382-390
|
artikel
|
| 7 |
A Randomised Trial of Conventional Care versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
|
Khoo, V.
|
|
2018
|
30 |
6 |
p. e64
|
artikel
|
| 8 |
A Request for Clarification Regarding the Advanced Radiotherapy Technologies Network (ART-NET)
|
Hartley, A.
|
|
2018
|
30 |
6 |
p. 391
|
artikel
|
| 9 |
A Single Centre Multi-modality Plan Comparison and Clinical Decision Matrix for Nodal Oligometastatic Disease
|
Jackson, T.
|
|
2018
|
30 |
6 |
p. e61
|
artikel
|
| 10 |
Assessment of mGTV Reduction when using Abdominal Compression in SABR Treatments of Oligometastatic Disease to the Adrenal Gland: a Single Institution Case Series
|
Watkins, S.
|
|
2018
|
30 |
6 |
p. e62
|
artikel
|
| 11 |
A Survey of Women's Experience with Treatment for Breast Cancer on Long-term Employment
|
Dadhania, S.
|
|
2018
|
30 |
6 |
p. e42
|
artikel
|
| 12 |
Audit of Bone-modifying Treatment in Metastatic Breast Cancer at a Single Breast Unit
|
Scott, E.
|
|
2018
|
30 |
6 |
p. e46-e47
|
artikel
|
| 13 |
Bladder Filling for PACE SABR Prostate Patients Receiving Radiotherapy: What is the Optimum Bladder Preparation Protocol? An Audit of Two Bladder Filling Regimes
|
Blower, A.
|
|
2018
|
30 |
6 |
p. e58-e59
|
artikel
|
| 14 |
Cancer Patients with Undiagnosed and Poorly Managed Diabetes Mellitus
|
Kim, S.
|
|
2018
|
30 |
6 |
p. e44
|
artikel
|
| 15 |
Can Everolimus in Combination with Exemestane, for Metastatic Breast Patients, be Delivered in a Health Care Professional Led Clinic. A Retrospective Service Evaluation from a South Yorkshire Population
|
Ghazi, S.
|
|
2018
|
30 |
6 |
p. e44
|
artikel
|
| 16 |
Choice of Flattening Filter Free (FFF) Energy for Treating Lung SABR
|
Marsden, J.
|
|
2018
|
30 |
6 |
p. e52
|
artikel
|
| 17 |
Consider the Radiation Dose to the Kidneys During Intensity Modulated Breast Cancer Treatment
|
Stewart, S.
|
|
2018
|
30 |
6 |
p. e47
|
artikel
|
| 18 |
Could Women with Biopsy Proven Lymph Node Positive Breast Cancer and Response to Primary Chemotherapy Avoid Axillary Lymph Node Clearance?
|
Germanou, S.
|
|
2018
|
30 |
6 |
p. e43-e44
|
artikel
|
| 19 |
Curative Treatment Rates and Use of Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer (NSCLC) in England
|
Harden, S.
|
|
2018
|
30 |
6 |
p. e50
|
artikel
|
| 20 |
Defining the Older Patient Population (>65 Years) Treated for Metastatic Breast Cancer (mBC) Within the Sussex Cancer Network
|
DeSouza, K.
|
|
2018
|
30 |
6 |
p. e43
|
artikel
|
| 21 |
Development of an Outcomes Database for the SABR CtE Scheme
|
Carver, A.
|
|
2018
|
30 |
6 |
p. e52
|
artikel
|
| 22 |
4D Imaging Experience for Treatment of Lung SBRT
|
Hassan, S.
|
|
2018
|
30 |
6 |
p. e59
|
artikel
|
| 23 |
Does a Central Stereotactic Ablative Radiotherapy (SABR) Multidisciplinary Team (MDT) for Early Stage Lung Cancer Influence Patient Outcome?
|
Moore, K.
|
|
2018
|
30 |
6 |
p. e62
|
artikel
|
| 24 |
Dosimetric Comparison of MR-Linac and Cyberknife Plans for Non-spine Bone and Nodal Metastases
|
Mehta, S.
|
|
2018
|
30 |
6 |
p. e51
|
artikel
|
| 25 |
Dosimetric Impact of Daily Variations to Organs at Risk during Prostate Stereotactic Ablative Radiotherapy Treatment Delivery
|
Devlin, L.
|
|
2018
|
30 |
6 |
p. e49
|
artikel
|
| 26 |
Dosimetric Impact of Moving to Acuros (AXB) and Dose to Medium for SABR Spine
|
Nic A Bhaird, S.
|
|
2018
|
30 |
6 |
p. e61
|
artikel
|
| 27 |
Efficacy of Prophylactic Radiotherapy in the Treatment of Heterotopic Ossification
|
Tao, MJ.
|
|
2018
|
30 |
6 |
p. 393-395
|
artikel
|
| 28 |
Evaluation of the Implementation of Abdominal Compression for Liver and Adrenal SABR
|
Bode, C.
|
|
2018
|
30 |
6 |
p. e61
|
artikel
|
| 29 |
Evolving and Improving Lung SABR Planning Technique
|
Brookes, L.
|
|
2018
|
30 |
6 |
p. e63-e64
|
artikel
|
| 30 |
EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-resistant Prostate Cancer
|
Jenkins, V.
|
|
2018
|
30 |
6 |
p. 331-333
|
artikel
|
| 31 |
Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer
|
Meade, S.
|
|
2018
|
30 |
6 |
p. 366-374
|
artikel
|
| 32 |
First-line Treatment Modality for Metastatic Breast Cancer: A Single Institution Outcome Analysis by Metastatic Site and Molecular Subtype
|
Sim, V.
|
|
2018
|
30 |
6 |
p. e47
|
artikel
|
| 33 |
Head and Neck Contouring Peer Review
|
Cole, N.
|
|
2018
|
30 |
6 |
p. 393
|
artikel
|
| 34 |
Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma
|
Grønhøj, C.
|
|
2018
|
30 |
6 |
p. 375-381
|
artikel
|
| 35 |
Implementation of 6 Monthly Bisphosphonate Infusions in Postmenopausal Adjuvant Breast Cancer Patients in a DGH in North Wales
|
Wreglesworth, N.
|
|
2018
|
30 |
6 |
p. e47
|
artikel
|
| 36 |
Implementation of Stereotactic Ablative Body Radiotherapy (SABR) for Spinal Oligometatases: Initial Experiences
|
Smyth, M.
|
|
2018
|
30 |
6 |
p. e57
|
artikel
|
| 37 |
Late Toxicity Following SABR with Multi-modality Imaging and Flattening Filter Free for Low–Intermediate Risk Prostate Cancer
|
Duffton, A.
|
|
2018
|
30 |
6 |
p. e62-e63
|
artikel
|
| 38 |
Loco-regional Recurrence After 3-field Breast Radiotherapy
|
Sarkodie, T.
|
|
2018
|
30 |
6 |
p. e46
|
artikel
|
| 39 |
LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located Non-small Cell Lung Cancer (NSCLC)
|
Faivre-Finn, C.
|
|
2018
|
30 |
6 |
p. e65
|
artikel
|
| 40 |
Metaplastic Breast Cancer (MBC): A Single Centre Experience
|
Kipps, E.
|
|
2018
|
30 |
6 |
p. e44-e45
|
artikel
|
| 41 |
Metronomic Cyclophosphamide and Methotrexate Chemotherapy in Patients with Heavily Pretreated Metastatic Breast Cancer: A Useful Palliative Regimen?
|
Rush, H.
|
|
2018
|
30 |
6 |
p. e45-e46
|
artikel
|
| 42 |
Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer
|
Lemanska, A.
|
|
2018
|
30 |
6 |
p. 334-345
|
artikel
|
| 43 |
Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
|
Rush, H.
|
|
2018
|
30 |
6 |
p. e46
|
artikel
|
| 44 |
Outcomes Data of Lung SABR from a Single UK Centre, including Case Study
|
Marsden, J.
|
|
2018
|
30 |
6 |
p. e60-e61
|
artikel
|
| 45 |
Outcomes of a Series of 237 Patients with Early Stage Peripheral NSCLC, Treated by SABR in a Single Institution Non-academic Setting
|
Veeratterapillay, J.
|
|
2018
|
30 |
6 |
p. e55-e56
|
artikel
|
| 46 |
Outcomes of Everolimus plus Exemestane in ER-positive, HER2-negative Heavily Pre-treated Metastatic Breast Cancer Patients: A Real Life Multicentre Experience
|
Desai, P.
|
|
2018
|
30 |
6 |
p. e42-e43
|
artikel
|
| 47 |
Patterns of Disease Progression in Patients with Local and Metastatic Breast Cancer as Evaluated by Whole-body MRI
|
Kosmin, M.
|
|
2018
|
30 |
6 |
p. e45
|
artikel
|
| 48 |
Performance of CT-based High Risk Features (HRFs) in Predicting Local Recurrence following SABR for NSCLC: Analysis of the First 100 Cases Referred to a UK Tertiary Centre
|
Hargreaves, S.
|
|
2018
|
30 |
6 |
p. e56-e57
|
artikel
|
| 49 |
Pertuzumab as Part of Triple Therapy in HER-2 Positive Metastatic Breast Cancer
|
Eslamian, G.
|
|
2018
|
30 |
6 |
p. e43
|
artikel
|
| 50 |
Plan Quality Comparison between CK and IMRT for SABR Prostate Patients with Prosthetic Hips
|
Sturt, P.
|
|
2018
|
30 |
6 |
p. e60
|
artikel
|
| 51 |
Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
|
Gray, C.
|
|
2018
|
30 |
6 |
p. e56
|
artikel
|
| 52 |
Radiation Necrosis following SRS for Brain Metastases: is there an Increased Incidence with Immunotherapy and Targeted Therapy?
|
Colaco, R.
|
|
2018
|
30 |
6 |
p. e63
|
artikel
|
| 53 |
RCR Meetings
|
|
|
2018
|
30 |
6 |
p. I
|
artikel
|
| 54 |
Really Rapid Rapid Arc using FFF for SABR Treatments and its Effect on Post-treatment Shifts
|
Hallam, L.
|
|
2018
|
30 |
6 |
p. e56
|
artikel
|
| 55 |
Referrals Patterns to an Oncology Clinical Advice Service
|
Walls, G.M.
|
|
2018
|
30 |
6 |
p. 395-396
|
artikel
|
| 56 |
Response to a Request for Clarification Regarding the Advanced Radiotherapy Technologies Network (ART-NET)
|
Faivre-Finn, C.
|
|
2018
|
30 |
6 |
p. 391-393
|
artikel
|
| 57 |
Role of Functional Imaging (Choline PET/CT) in Assessing Response to Stereotactic Radiotherapy to Oligometastatic LN Disease from Prostate Cancer
|
Zarkar, A.
|
|
2018
|
30 |
6 |
p. e57
|
artikel
|
| 58 |
Routine Use of Elekta Active Breathing Coordinator (ABC) for SABR
|
Kinsman, J.
|
|
2018
|
30 |
6 |
p. e60
|
artikel
|
| 59 |
SABR for Hepatocellular Carcinoma: Efficacy and Toxicity Analysis of a Single-centre Cohort Treated within the NHS England Commissioning through Evaluation Programme
|
Good, J.
|
|
2018
|
30 |
6 |
p. e62
|
artikel
|
| 60 |
SBRT for Mediastinal Nodal Oligometastatic Disease – Initial Outcomes
|
Cooke, R.
|
|
2018
|
30 |
6 |
p. e51
|
artikel
|
| 61 |
Should Multiple SABRs Leave you Breathless? Toxicity and Outcomes at University Hospital Birmingham
|
Stange, D.
|
|
2018
|
30 |
6 |
p. e65
|
artikel
|
| 62 |
Stereotactic Ablative Body Radiotherapy for Metastatic Prostate Cancer: Retrospective Review of a Complex Case
|
Laycock, P.
|
|
2018
|
30 |
6 |
p. e55
|
artikel
|
| 63 |
Stereotactic Body Radiotherapy for Oligometastatic and Oligoprogressive Disease
|
Pembroke, C.
|
|
2018
|
30 |
6 |
p. e52
|
artikel
|
| 64 |
Stereotactic Radiosurgery for Brain Oligometastases: a One-year Single Centre Experience
|
Ho, J.
|
|
2018
|
30 |
6 |
p. e64
|
artikel
|
| 65 |
Stereotactic Radiosurgery for Intracranial Metastases from Breast Cancer: A Single Centre Experience
|
de Paiva, R.
|
|
2018
|
30 |
6 |
p. e42
|
artikel
|
| 66 |
Targeted Therapy With or Without Dose-intensified Radiotherapy in Oligoprogressive Disease in Oncogene Addicted Lung Tumours
|
McDonald, F.
|
|
2018
|
30 |
6 |
p. e64-e65
|
artikel
|
| 67 |
The Challenges of SABR Re-irradiation of Spinal Vertebra in Oligometastatic Lung Cancer
|
Dean, C.
|
|
2018
|
30 |
6 |
p. e52
|
artikel
|
| 68 |
The Evaluation of Stereotactic Body Radiotherapy for Oligometastastic Spinal Metastases
|
Chaw, C.L.
|
|
2018
|
30 |
6 |
p. e50-e51
|
artikel
|
| 69 |
The Impact of Denosumab on Symptomatic Bone Metastases?
|
Kwok, J.
|
|
2018
|
30 |
6 |
p. e45
|
artikel
|
| 70 |
The Role for Expiratory Gated Volume Definition and Treatment Delivery in Pancreatic Radiotherapy for SABR
|
Houston, P.
|
|
2018
|
30 |
6 |
p. e61
|
artikel
|
| 71 |
The Use of Abdominal Compression to Facilitate SABR to Lower Lobe Lung Tumours
|
Garikipati, S.
|
|
2018
|
30 |
6 |
p. e52-e53
|
artikel
|
| 72 |
Three Years of Experience with Trastuzumab Emtansine at the Lister Hospital, Stevenage
|
Joshi, P.V.
|
|
2018
|
30 |
6 |
p. e44
|
artikel
|
| 73 |
Toxicity and Efficacy of SABR using 50 Gy in 5 Fractions for Central, Inoperable Lung Tumours
|
Rulach, R.
|
|
2018
|
30 |
6 |
p. e50
|
artikel
|
| 74 |
Trastuzumab Emsantine-related Toxicities and Haemorrhagic Complications in Metastatic Breast Cancer: A Case Series
|
Cheng, L.
|
|
2018
|
30 |
6 |
p. e42
|
artikel
|
| 75 |
Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients
|
Wan, B.A.
|
|
2018
|
30 |
6 |
p. 354-365
|
artikel
|
| 76 |
Treatment Planning of Stereotactic Radiosurgery (SRS) for Patients with Brain Metastases: Plan Quality Assessment of Hippocampal Avoidance
|
Davies, C.
|
|
2018
|
30 |
6 |
p. e63
|
artikel
|
| 77 |
Use of Video-consultation is Feasible During Follow-up Care of Patients with a Neuroendocrine Tumour
|
Bouma, G.
|
|
2018
|
30 |
6 |
p. 396
|
artikel
|
Tijdschrift beschrijving